Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.


Partner Beverly Lyman expands firm’s deep biotechnology capabilities

BakerHostetler is proud to announce that Beverly Lyman, Ph.D., has joined the firm as a partner in the Intellectual Property practice as a member of the Biotechnology, Chemical and Pharmaceutical team. She is resident in the Cincinnati and Atlanta offices. Lyman was previously at Thompson Hine.

Lyman brings more than 20 years of experience as a life sciences transactional patent attorney. Her strategic and efficient counsel focuses on clients’ business goals to bring their IP potential to the forefront to leverage assets and maximize portfolio value. She advises clients through all aspects of intellectual property law, including patent procurement, licensing, evaluation and enforcement. Her extensive work in transactions and IP monetization helps companies commercialize innovative technologies and bring products to the marketplace. She represents corporations, early-stage companies, entrepreneurs, universities and physicians across the biotechnology, pharmaceutical, medical device and chemical industries. Lyman has represented global life science corporations in cutting-edge technologies such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR). Previously, she was a faculty member of the University of Tennessee where she taught biotechnology and chemical patent strategy, as well as taught IP licensing at the University of Cincinnati College of Law. Lyman’s former academic career guides her understanding of commercial integration among academic institutions from the undergraduate level to professional schools.

Lyman is registered to practice before the U.S. Patent and Trademark Office and is admitted in Ohio and Georgia. She has led and argued ex parte and inter partes reviews and appeals, and post-grant proceedings. She handles contracts, joint development agreements, material transfers and affiliations. She has advised clients through the development and commercialization of FDA-approved synthetics for burn patients; medical devices that manage pain; applications to treat burns and pathologies; compounds used in diagnostic imaging; topical solutions to treat eye conditions; and compounds to treat wounds and diabetic ulcers.

“Beverly is a valuable asset to our national practice,” said Mark Tidman, chair of BakerHostetler’s Intellectual Property Group. “Her skills, knowledge of advanced sciences and pragmatic approach to offering creative strategies will benefit corporate clients and open doors for academic researchers.”

“Beverly is a talented patent attorney who complements our Cincinnati office as we continue to grow,” said Dave Holcombe, partner-in-charge of the Cincinnati office. “She broadens our experience in Ohio with her life sciences background and network of clients in our market.”

“I’m excited to welcome Beverly to the Atlanta office,” said Joann Gallagher Jones, managing partner of the Atlanta office. “This continues to be a growing market for BakerHostetler, and Beverly’s practice will build on our strong reputation in intellectual property in the region.”

“Joining BakerHostetler provides a larger platform for my practice,” said Lyman. “The firm has sophisticated capabilities in IP, life sciences, corporate and health law, as well as a robust FDA practice. These resources create efficiencies and unify the process of solving problems for clients.”

Lyman is a nationally ranked Chambers USA intellectual property attorney. She was recognized by the Ohio Diversity Council among its Top Business Women in Ohio in 2017. Lyman is a member of the American Bar Association’s Health Law Section.

As an academic, Lyman has authored numerous scientific publications, including chapters in clinical texts and a biochemistry study guide. She received her J.D. from the University of Memphis Cecil C. Humphreys Law School in 1996. Lyman earned a Ph.D. in 1986 and master of science in biochemistry in 1984 from Hahnemann Medical College. She received a master of science in education from the University of Pennsylvania in 1982 and a bachelor of science in medical technology from Thomas Jefferson University in 1978.

Lyman follows the recent addition of two intellectual property litigation partners earlier this month. These recent additions enhance the continued growth of the IP group and bolster the firm’s national intellectual property footprint. BakerHostetler’s Intellectual Property Group has more than 160 dedicated IP attorneys, with more than 100 lawyers and patent agents registered to practice before the U.S. Patent and Trademark Office. More than 50 of its IP attorneys hold advanced degrees across a spectrum of scientific disciplines.